Drug6 min read

Tiratricol FDA approval: targets and potency in BioQ

Tiratricol FDA approval (Emcitate): ChEMBL shows 68 targets, THRB and THRA top by pChEMBL, and 3 registered trials on ClinicalTrials.gov, as of 2026-11-17.

Data as of November 17, 2026 · By the BioQ team

BioQ results page for the query tiratricol, showing a ranked list of ChEMBL targets with pChEMBL values and the registered trials below.

After the tiratricol FDA approval (Emcitate, sponsor Rare Thyroid), ChEMBL lists 68 targets for the compound, 26 of them with exact measurements. The highest pChEMBL values are on THRB (10.39) and THRA (9.85). ClinicalTrials.gov returns 3 registered studies. All data are as of 2026-11-17.

What we asked about tiratricol after the FDA approval

The FDA application record names Emcitate (tiratricol) with Rare Thyroid as sponsor and gives an original approval date of 2026-09-28. A label milestone raises the same practical questions for a researcher who has not worked with the compound before:

  • Which proteins has tiratricol been measured against, and how strongly?
  • Which trials are registered, and in what state?
  • Is the compound identity unambiguous across databases?

We ran one query, tiratricol, and let BioQ split it across the relevant data layers. This post reads only what came back. It does not cover the label text, the indication wording or anything about clinical use.

What BioQ returned

The query ran 3 engine queries in 2.68 seconds in total and drew on 3 distinct resources: ChEMBL, ClinicalTrials.gov and PubChem. Every row below carries its source.

Compound identity. PubChem lists the compound under CID 5803 with InChIKey UOWZUVNAGUAEQC-UHFFFAOYSA-N and 21 synonyms. It maps to a single ChEMBL entry, CHEMBL41632. That one-to-one mapping matters because the later tables depend on it.

Measured targets and potency. ChEMBL holds activity data for 68 targets of CHEMBL41632, and 26 of them have exact (not censored) measurements. The table shows the top 8 by highest pChEMBL. pChEMBL is the negative log10 of the molar potency, so a higher value means a stronger measured effect for that assay type.

ChEMBL targetGeneBest pChEMBLTypeExact measurements
CHEMBL1947THRB10.39IC504
CHEMBL1860THRA9.85IC503
CHEMBL3917THRB9.82IC501
CHEMBL376—9.1KI1
CHEMBL235PPARG6.7KD3
CHEMBL2061RXRA5.88KD2
CHEMBL2073688SLCO1C15.67KI1
CHEMBL5303741GABRA1, GABRB2, GABRG2, GABRA25.64AC501
BioQ target view for tiratricol listing ChEMBL targets with gene symbols, best pChEMBL, assay type and exact measurement counts
Target view for the query tiratricol in BioQ

Registered trials. ClinicalTrials.gov returns 3 studies with tiratricol as the intervention. By phase there are 0 in phase 1, 1 in phase 2 and 1 in phase 3. The remaining record has no phase value.

TrialPhaseStatusSponsorStartEnrollment
NCT02396459PHASE2ACTIVE_NOT_RECRUITINGRare Thyroid Therapeutics International2020-1222
NCT05911399—APPROVED_FOR_MARKETINGRare Thyroid Therapeutics International——
NCT05579327PHASE3COMPLETEDRare Thyroid Therapeutics International2023-0720

What it means and how to read it

Target profile. The three strongest entries are thyroid hormone receptor records. THRB appears twice (CHEMBL1947 at 10.39 with 4 exact measurements, and CHEMBL3917 at 9.82 with 1), and THRA appears once (CHEMBL1860 at 9.85 with 3). All three are IC50 values. The mechanism-of-action reading from this table is therefore a thyroid hormone receptor ligand. That is what the measured data show, not a statement about the label.

CHEMBL376 sits fourth at 9.1 as a KI value, but the table shows no gene symbol for it. Check that target record in ChEMBL before drawing conclusions from it.

Further down, the values are lower on the same scale. PPARG has 6.7 (KD, 3 exact measurements) and RXRA has 5.88 (KD, 2). SLCO1C1 has 5.67 (KI), and a GABA receptor complex (GABRA1, GABRB2, GABRG2, GABRA2) has 5.64 (AC50). Assay types differ between rows (IC50, KI, KD, AC50), so compare values within a type with care. A pChEMBL value is a ranking aid, not proof of selectivity.

Counts of exact measurements. Several top rows rest on a single exact measurement (CHEMBL3917, CHEMBL376, SLCO1C1). A value from one measurement is a lead to check in the source assay, not a settled potency.

Trials. The 3 records are all from Rare Thyroid Therapeutics International. NCT02396459 is a phase 2 study, active but not recruiting, with a start of 2020-12 and enrollment of 22. NCT05579327 is a phase 3 study, completed, with a start of 2023-07 and enrollment of 20. NCT05911399 carries the status APPROVED_FOR_MARKETING and no phase or enrollment value. This status is the registry's wording for the approval milestone.

Placement among drugs on the same target. This query does not rank tiratricol against other compounds. To see where it sits among other drugs on THRB or THRA, run the target as a second query. Compare only like with like: the same assay type and exact measurements.

Why one query. The facts above come from 3 resources and 3 engine queries that finished in 2.68 seconds. Doing the same by hand means resolving the compound name in PubChem, finding the ChEMBL record, filtering activities to exact values and then searching the trial registry. BioQ does these steps in one pass and names the source on every row.

How to reproduce it in BioQ

  1. Open BioQ and paste the query below as written.
tiratricol

Open this query in BioQ

  1. Read the compound identity first and confirm CHEMBL41632 is the entry you mean.
  2. In the target view, sort by best pChEMBL and check the exact-measurement count for each row you plan to cite.
  3. Open the trial list and note phase, status and sponsor for each record.
  4. To compare with other drugs on the same target, run THRB or THRA as a new query and filter to the same assay type.

Limits: what the data do not show

  • The data do not describe the approved indication, dosing or conditions of use. Read the FDA label for that. Nothing here is treatment advice.
  • ChEMBL values come from published assays with different formats and conditions. A high pChEMBL value on a purified receptor does not translate directly into activity in patients.
  • The 68 targets include weak and single-measurement entries. Only 26 have exact measurements, and the table shows just the top 8.
  • One target row has no gene symbol in this view, so its identity needs a manual check.
  • The trial list is limited to what ClinicalTrials.gov matched for the intervention name. It may miss studies registered under other names or in other registries. Enrollment numbers are small, and the table says nothing about outcomes.
  • The query does not rank tiratricol against other drugs, so no claim about its position among drugs on the same target can be drawn from it.

Data and method

The numbers on this page were read from the BioQ engine on 2026-11-17 (3 queries, 2.7 s of engine time in total). The tables are generated by code from the engine's answers; the text only restates them.

/chembl_potency, /clinicaltrials, /compound

Sources

Run the same query yourself: tiratricol

For research use only. This page summarises public data and is not medical advice.

BioQ is an AI search engine and agent with one goal: making biology research 100X faster. Ask in the web app, over the REST API, or from Claude, ChatGPT or Cursor through MCP.

Queries used

Frequently asked questions

What targets does tiratricol have in ChEMBL?

ChEMBL lists 68 targets for tiratricol (CHEMBL41632), 26 of them with exact measurements. The highest pChEMBL values are on THRB (10.39) and THRA (9.85).

How many clinical trials of tiratricol are registered?

ClinicalTrials.gov returns 3 studies with tiratricol as the intervention: 1 in phase 2, 1 in phase 3 and 1 record with no phase value and the status APPROVED_FOR_MARKETING. All 3 list Rare Thyroid Therapeutics International as sponsor.

What does pChEMBL mean for tiratricol potency?

pChEMBL is the negative log10 of the molar potency, so a higher value means a stronger measured effect. For tiratricol the top value is 10.39 on THRB (IC50, 4 exact measurements).

Does BioQ show tiratricol off-targets?

Yes, as measured activities. Besides the thyroid hormone receptors, the table lists PPARG at 6.7, RXRA at 5.88, SLCO1C1 at 5.67 and a GABA receptor complex at 5.64. Several of these rest on 1 to 3 exact measurements, so check the source assays.

How long does the tiratricol query take in BioQ?

The engine ran 3 queries in 2.68 seconds in total, drawing on 3 distinct resources: ChEMBL, ClinicalTrials.gov and PubChem. Data are as of 2026-11-17.

Sources

  1. Source FDA application NDA220963: EMCITATE (tiratricol), sponsor RARE THYROID (2026)
  2. Dataset ClinicalTrials.gov
  3. Dataset PubChem

Results come from public databases as of the date shown and may change. BioQ gives research information, not medical advice.

More from the blog